APEIRON Respiratory Therapies announces positive results from Phase I trial of inhaled APN01 Administration of aerosolized APN01 shown to be safe and well tolerated at all dose levels, with no adverse events above Grade 2Investigators recommend further development of inhaled APN01, which may...